Sanofi, WC Heraeus Drop Patent Spat Over Eloxatin
Sanofi-Aventis U.S. LLC has agreed to release German precious metals company W.C. Heraeus GmbH from a lawsuit accusing several generic-drug makers of infringing the patents for the colon cancer drug Eloxatin....To view the full article, register now.
Already a subscriber? Click here to view full article